Low Incidence of Clean Intermittent Catheterisation With OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients With Corresponding Improvements in Urinary Symptoms, Treatment Response, and Quality of Life

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 313
	Female Pelvic Floor 3 Scientific Podium Short Oral Session 18
	Wednesday 13th September 2017
	17:22 - 17:30
	Spadolini F
	Overactive Bladder Clinical Trial Incontinence Detrusor Overactivity Quality of Life (QoL)
	1. New York University Langone Medical Center, New York, NY, USA, 2. Bristol Urological Institute, Bristol, UK, 3. Ghent University Hospital, Ghent, Belgium, 4. Medical University of South Carolina, Charleston, SC, USA, 5. Vanderbilt University Medical Center, Nashville, TN, USA, 6. USC Institute of Urology, Los Angeles, CA, USA, 7. University of Toronto, Toronto, Canada, 8. Allergan plc, Irvine, CA, USA, 9. Allergan plc, Bridgewater, NJ, USA, 10. The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, UK
Presenter
V Victor Nitti New York University Langone Medical Center, New York, NY, USA
Abstract PDF Edit Abstract Abstract Centre